Cas no 27430-18-8 (5-(furan-2-yl)methylidene-2-sulfanylidene-1,3-diazinane-4,6-dione)
5-(furan-2-yl)methylidene-2-sulfanylidene-1,3-diazinane-4,6-dione Chemical and Physical Properties
Names and Identifiers
-
- 4,6(1H,5H)-Pyrimidinedione,5-(2-furanylmethylene)dihydro-2-thioxo-
- 5-(furan-2-ylmethylidene)-2-sulfanylidene-1,3-diazinane-4,6-dione
- 5-(2-furanylmethylene)dihydro-2-thioxo-4,6(1H,5H)-pyrimidinedione
- 5-(2-furylmethylene)-2-thioxo-1,3-dihydropyr
- 5-(furan-2'-ylmethylidene)-2-thioxodihydropyrimidine-4,6(1H,5H)-dione
- 5-furan-2-ylmethylene-2-thioxodihydropyrimidine-4,6-dione
- 5-Furfuryliden-2-thio-barbitursaeure
- 5-furfurylidene-2-thio-barbituric acid
- 5-furfurylidene-2-thioxo-dihydro-pyrimidine-4,6-dione
- AC1LDWVB
- AC1Q79A0
- CTK4F9671
- NSC96626
- ST021624
- STOCK1S-56117
- 5-(furan-2-yl)methylidene-2-sulfanylidene-1,3-diazinane-4,6-dione
- CCG-53892
- BDBM50534267
- AKOS030659818
- 5-(furan-2-ylmethylidene)-2-sulfanylidene-1, 3-diazinane-4, 6-dione
- SDCCGMLS-0065342.P001
- SCHEMBL3181280
- CS-0238656
- 5-(furan-2-ylmethylene)-2-thioxodihydropyrimidine-4,6(1H,5H)-dione
- DTXSID20350317
- 27430-18-8
- AKOS000521283
- HMS1607J07
- NSC-96626
- EN300-198955
- 5-[(Furan-2-yl)methylidene]-2-sulfanylidenedihydropyrimidine-4,6(1H,5H)-dione
- CBA43018
- F0777-0749
- 5-[(Furan-2-yl)methylidene]-4,6-dihydroxy-2,5-dihydropyrimidine-2-thione
- AB00682070-01
- Z237732478
- 5-[(furan-2-yl)methylidene]-2-sulfanylidene-1,3-diazinane-4,6-dione
- NSC 96626
- SR-01000643022-1
- AKOS001036274
- 5-FURFURYLIDENE-2-THIOBARBITURICACID
- AB00123094-02
- CHEMBL4537015
- 5-Furfurylidene-2-Thiobarbituric Acid
- CD00509
- STK970592
- 5-(furan-2-ylmethylidene)-2-thioxodihydropyrimidine-4,6(1H,5H)-dione
- (5E)-5-(furan-2-ylmethylidene)-2-sulfanylpyrimidine-4,6(1H,5H)-dione
- G54712
- STL296169
- GLXC-03367
- DA-49671
- TS-09072
-
- MDL: MFCD00020968
- Inchi: 1S/C9H6N2O3S/c12-7-6(4-5-2-1-3-14-5)8(13)11-9(15)10-7/h1-4H,(H2,10,11,12,13,15)
- InChI Key: VQRARDATQWRHGF-UHFFFAOYSA-N
- SMILES: S=C1NC(/C(/C(N1)=O)=C\C1=CC=CO1)=O
Computed Properties
- Exact Mass: 222.00998
- Monoisotopic Mass: 222.009913
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 2
- Hydrogen Bond Acceptor Count: 5
- Heavy Atom Count: 15
- Rotatable Bond Count: 1
- Complexity: 342
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- Topological Polar Surface Area: 103
- XLogP3: 0.7
Experimental Properties
- Color/Form: No data available
- Density: 1.54
- Melting Point: Not available
- Boiling Point: °Cat760mmHg
- Flash Point: °C
- Refractive Index: 1.685
- PSA: 71.34
- LogP: 0.85150
- Vapor Pressure: Not available
5-(furan-2-yl)methylidene-2-sulfanylidene-1,3-diazinane-4,6-dione Security Information
- Signal Word:warning
- Hazard Statement: H303May be harmful if swallowed+H313Skin contact may be harmful+H333Inhalation may be harmful to the body
-
Warning Statement:
P264Thoroughly clean after treatment
P280Wear protective gloves/Wear protective clothing/Wear protective goggles/Wear a protective mask
P305If it enters the eyes
P351Rinse carefully with water for a few minutes
P338Remove the contact lens(If any)And easy to operate,Continue flushing
P337If eye irritation persists
P313Obtain medical advice/care - Safety Instruction: H303May be harmful if swallowed+H313Skin contact may be harmful+H333Inhalation may be harmful to the body
- Storage Condition:storage at -4℃ (1-2weeks), longer storage period at -20℃ (1-2years)
5-(furan-2-yl)methylidene-2-sulfanylidene-1,3-diazinane-4,6-dione Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| TRC | F864628-250mg |
5-Furfurylidene-2-thiobarbituric Acid |
27430-18-8 | 250mg |
$ 201.00 | 2023-04-15 | ||
| TRC | F864628-500mg |
5-Furfurylidene-2-thiobarbituric Acid |
27430-18-8 | 500mg |
$ 70.00 | 2022-01-08 | ||
| TRC | F864628-2.5g |
5-Furfurylidene-2-thiobarbituric Acid |
27430-18-8 | 2.5g |
$ 295.00 | 2022-01-08 | ||
| TRC | F864628-50mg |
5-Furfurylidene-2-thiobarbituric Acid |
27430-18-8 | 50mg |
$ 69.00 | 2023-04-15 | ||
| TRC | F864628-100mg |
5-Furfurylidene-2-thiobarbituric Acid |
27430-18-8 | 100mg |
$ 110.00 | 2023-04-15 | ||
| Enamine | EN300-198955-0.05g |
5-[(furan-2-yl)methylidene]-4,6-dihydroxy-2,5-dihydropyrimidine-2-thione |
27430-18-8 | 95.0% | 0.05g |
$109.0 | 2025-03-21 | |
| Enamine | EN300-198955-0.1g |
5-[(furan-2-yl)methylidene]-4,6-dihydroxy-2,5-dihydropyrimidine-2-thione |
27430-18-8 | 95.0% | 0.1g |
$163.0 | 2025-03-21 | |
| Enamine | EN300-198955-0.25g |
5-[(furan-2-yl)methylidene]-4,6-dihydroxy-2,5-dihydropyrimidine-2-thione |
27430-18-8 | 95.0% | 0.25g |
$233.0 | 2025-03-21 | |
| Enamine | EN300-198955-0.5g |
5-[(furan-2-yl)methylidene]-4,6-dihydroxy-2,5-dihydropyrimidine-2-thione |
27430-18-8 | 95.0% | 0.5g |
$366.0 | 2025-03-21 | |
| Enamine | EN300-198955-1.0g |
5-[(furan-2-yl)methylidene]-4,6-dihydroxy-2,5-dihydropyrimidine-2-thione |
27430-18-8 | 95.0% | 1.0g |
$470.0 | 2025-03-21 |
5-(furan-2-yl)methylidene-2-sulfanylidene-1,3-diazinane-4,6-dione Related Literature
-
Piotr Szcze?niak,Sebastian Stecko RSC Adv., 2015,5, 30882-30888
-
Kanjun Sun,Fengting Hua,Shuzhen Cui,Yanrong Zhu,Hui Peng,Guofu Ma RSC Adv., 2021,11, 37631-37642
-
4. An integrated microfluidic 3D tumor system for parallel and high-throughput chemotherapy evaluation?Dan Liu,Rui Hu,Zhongchao Huang,Meilin Sun,Kai Han Analyst, 2020,145, 6447-6455
-
Xin Fu,Qing-rong Liang,Rong-guang Luo,Yan-shu Li,Xiao-ping Xiao,Lu-lu Yu,Wen-zhe Shan,Guang-qin Fan J. Mater. Chem. B, 2019,7, 3088-3099
Additional information on 5-(furan-2-yl)methylidene-2-sulfanylidene-1,3-diazinane-4,6-dione
Recent Advances in the Study of 5-(furan-2-yl)methylidene-2-sulfanylidene-1,3-diazinane-4,6-dione (CAS: 27430-18-8)
The compound 5-(furan-2-yl)methylidene-2-sulfanylidene-1,3-diazinane-4,6-dione (CAS: 27430-18-8) has recently garnered significant attention in the field of chemical biology and medicinal chemistry due to its unique structural features and potential therapeutic applications. This research briefing aims to provide an overview of the latest findings related to this compound, focusing on its synthesis, biological activities, and potential mechanisms of action.
Recent studies have highlighted the synthetic versatility of 5-(furan-2-yl)methylidene-2-sulfanylidene-1,3-diazinane-4,6-dione. Researchers have developed novel synthetic routes to optimize yield and purity, with a particular emphasis on green chemistry principles to minimize environmental impact. The compound's furan and dithiocarbamate moieties are believed to contribute to its reactivity and biological activity, making it a promising candidate for further investigation.
In terms of biological activity, preliminary in vitro studies have demonstrated that 5-(furan-2-yl)methylidene-2-sulfanylidene-1,3-diazinane-4,6-dione exhibits potent inhibitory effects against a range of enzymes, including those involved in inflammatory pathways and cancer progression. Notably, its ability to modulate key signaling pathways, such as NF-κB and MAPK, suggests potential applications in the treatment of chronic inflammatory diseases and certain malignancies.
Mechanistic studies have further elucidated the compound's interactions at the molecular level. X-ray crystallography and molecular docking simulations have revealed that 5-(furan-2-yl)methylidene-2-sulfanylidene-1,3-diazinane-4,6-dione binds to specific active sites of target proteins, disrupting their function. These findings provide a solid foundation for the rational design of derivatives with enhanced potency and selectivity.
Despite these promising results, challenges remain in translating these findings into clinical applications. Issues such as bioavailability, metabolic stability, and potential toxicity need to be addressed through comprehensive preclinical studies. Future research directions may include the development of prodrug strategies or formulation technologies to improve the compound's pharmacokinetic profile.
In conclusion, 5-(furan-2-yl)methylidene-2-sulfanylidene-1,3-diazinane-4,6-dione represents a compelling area of research in chemical biology and drug discovery. Its unique structural features and diverse biological activities position it as a valuable scaffold for the development of novel therapeutic agents. Continued investigation into its mechanisms of action and optimization of its pharmacological properties will be crucial for realizing its full potential in medicine.
27430-18-8 (5-(furan-2-yl)methylidene-2-sulfanylidene-1,3-diazinane-4,6-dione) Related Products
- 63987-50-8(5-(furan-2-yl)methylidene-1,3-dimethyl-1,3-diazinane-2,4,6-trione)
- 339339-54-7(5-[(5-iodo-2-furyl)methylene]-2-thioxodihydropyrimidine-4,6(1H,5H)-dione)
- 27406-37-7(5-[(5-methylfuran-2-yl)methylidene]-1,3-diazinane-2,4,6-trione)
- 324068-37-3(5-(5-methylfuran-2-yl)methylidene-2-sulfanylidene-1,3-diazinane-4,6-dione)
- 260780-39-0(<br>5-((5-(4-bromophenyl)furan-2-yl)methylene)-2-thioxodihydropyrimidine-4,6(1H ,5H)-dione)
- 27406-36-6(5-(furan-2-yl)methylidene-1,3-diazinane-2,4,6-trione)
- 38307-83-4(4,6(1H,5H)-Pyrimidinedione,5-(2-furanylmethylene)dihydro-1,3-diphenyl-2-thioxo-)
- 99974-02-4(5-[(2E)-3-(furan-2-yl)prop-2-en-1-ylidene]-2-thioxodihydropyrimidine-4,6(1H,5H)-dione)
- 6509-66-6(Pyridinium,3-methyl-1-(3-methyl-2,4,6-trinitrophenyl)-, chloride (1:1))
- 425659-60-5(<br>5-[(5-iodo-2-furyl)methylene]-1,3-dimethyl-2-thioxodihydro-4,6(1H,5H)-pyrim idinedione)